Remove Doctors Remove Drug Development Remove Molecular Biology
article thumbnail

Case Study: Two Examples of Successful Automation Integration at Altasciences for Pharmacokinetic Studies

Alta Sciences

For a contract research organization (CRO), it can play an integral role in increasing the quality and speed of drug development while reducing costs, repetitive manual tasks, and human error. He began his career in academia, focusing on plant epigenetics and molecular biology in Paris, France.

article thumbnail

How organoids can redefine pre-clinical research

Drug Target Review

5 Organoids are recognised as New Alternative Methods (NAMs) in drug development. This recognition was codified by the United States Food and Drug Administration (FDA) in 2022 with the signing of the FDA Modernisation Act 2.0 This can aid in the development of safer, more effective therapeutic strategies. Front Genet.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Automated red blood cell exchange: bridging treatment gaps in sickle cell disease care

Drug Target Review

Aaron Haubner, PhD, MBA is the Senior Manager, North America Medical Affairs and Market Access at Terumo Blood and Cell Technologies Aaron earned his doctorate in pharmaceutical sciences and his MBA in finance.

Disease 52
article thumbnail

My Attendance at the 2024 Boston Society Cell and Gene Therapy Conference

Alta Sciences

One thing is for sure—regardless of how the field evolves around regulation requirements, Altasciences has the experience and range of capabilities to take on your gene therapy drug development programs. Connect with Dr.

article thumbnail

AI At The Frontier: Empowering Early Career Professionals In Drug Discovery

Elrig

Jasmine has a background in neuroscience and genetic manipulation, with early works focused on using a combined structural and molecular biology approach to assess disease-associated proteins implicated in Alzheimer’s disease. Bioinformatics is all about bringing together different areas of knowledge.

article thumbnail

Alzheimer’s disease: driving advancements with precision medicine

Drug Target Review

The Role of Biomarkers in Alzheimer’s Disease Drug Development. Progress in molecular biology and translational science. A how-to guide for a precision medicine approach to the diagnosis and treatment of alzheimer’s disease. link] Cummings J. Adv Exp Med Biol. 2019;1118:29-61. doi: 10.1007/978-3-030-05542-4_2.

Disease 59
article thumbnail

Kiromic Announces the Filing of Key European Patents for Its Chimeric PD-1 (chPD1) Target

The Pharma Data

Longwood has a robust research department with 7 post doctorates conducting research in molecular biology, microbiology, genomics, cancer biology, and immunology and publishing over 75 publications in different scientific journals in the past 5 years. Link to her profile: [link]. About Longwood University.